Jill Walker

机构：AstraZeneca (United Kingdom) · ORCID：0000-0001-7943-583X

发表论文 151 篇 · 总被引 3851 次 · h-index 24

代表论文

• Clinical Utility of Tumor-Naïve Presurgical Circulating Tumor DNA Detection in Early-Stage NSCLC (2024 · Journal of Thoracic Oncology · 被引 30)
• Immunomodulation by bepirovirsen may induce killing of infected hepatocytes (B-Together study) (2025 · Hepatology International · 被引 9)
• Outcomes in biomarker-selected subgroups from the KESTREL study of durvalumab and tremelimumab in recurrent or metastatic head and neck squamous cell carcinoma (2024 · Cancer Immunology Immunotherapy · 被引 9)
• Mutational Landscape of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Association with Immune Checkpoint Inhibitor Outcomes (2025 · Clinical Cancer Research · 被引 4)
• Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark (2023 · PLoS ONE · 被引 3)
• Abstract 3369: Utility of ctDNA-based targeted methylation MRD assay for hematological malignancies (2023 · Cancer Research · 被引 3)